Profusa (PFSA) Cash from Financing Activities (2023 - 2026)
Profusa (PFSA) posted quarterly Cash from Financing Activities of $28000.0 for Q1 2026, down 92.33% year-over-year from $365000.0 in Q1 2025, and down 99.43% quarter-over-quarter from $4.9 million in Q4 2025.
Profusa (PFSA) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Profusa's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $28000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 92.33% year-over-year to $28000.0; the TTM figure through Mar 2026 stood at $19.5 million (up 310.2% YoY), while the FY2025 annual figure was $19.8 million, up 838.2% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $28000.0, down from $4.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $20.9 million in Q3 2025, with the low at -$184.8 million in Q1 2023.
- The 4-year median for Cash from Financing Activities is $343426.0 (2023), against an average of -$12.4 million.
- Peak annual rise in Cash from Financing Activities reached 1597.58% in 2025, while the deepest fall reached 2025.11% in 2025.
- Profusa's Cash from Financing Activities stood at $408800.0 in 2023, then dropped by 29.31% to $289000.0 in 2024, then soared by 1597.58% to $4.9 million in 2025, then slumped by 99.43% to $28000.0 in 2026.
- Business Quant data shows PFSA's Cash from Financing Activities at $28000.0 in Q1 2026, $4.9 million in Q4 2025, and $20.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Profusa | 129,730.48 | -245,269.52 | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | 4.91 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -6.37 Mn |
| Mar 31, 2025 | 365,000.00 |
| Mar 31, 2025 | 365,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 330,796.00 |
| Jun 30, 2024 | 330,796.00 |
| Mar 31, 2024 | -2.28 Mn |
| Mar 31, 2024 | -2.28 Mn |
| Dec 31, 2023 | 408,800.00 |
| Dec 31, 2023 | 408,800.00 |